PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
The pituitary gland, often called the “master gland,” has fascinated medical professionals for centuries. Its role in regulating hormones was first recognized in the early 20th century, and by the 1950s, advancements in neurosurgery and radiology paved the way for better diagnosis and treatment of pituitary tumors. Over the decades, sophisticated imaging techniques and minimally invasive surgical approaches have significantly improved patient outcomes.
Pituitary adenomas are among the most common intracranial tumors, accounting for approximately 10-15% of all brain tumors. They affect individuals of all ages, though they are most frequently diagnosed in adults between 30 and 50 years old. According to global health studies, nearly 1 in 1,000 people may have a pituitary adenoma, but many remain undiagnosed due to their slow-growing nature and subtle symptoms.
While the exact cause remains unknown, certain risk factors and genetic conditions may contribute to the development of pituitary adenomas. Some of the known contributing factors include:
Symptoms vary depending on the tumor type, size, and whether it affects hormone production. Functioning adenomas secrete excess hormones, while non-functioning adenomas grow without producing hormones but may still cause pressure-related symptoms.
Early detection is essential for successful treatment. The diagnostic process typically involves:
The choice of treatment depends on the tumor’s size, location, and hormonal activity.
For hormone-secreting tumors, medications can regulate hormone levels and shrink the tumor:
Minimally invasive transsphenoidal surgery is the most common approach for removing pituitary adenomas. Surgeons access the tumor through the nasal cavity, minimizing complications and reducing recovery time.
For inoperable tumors or cases where residual tumor remains after surgery, stereotactic radiosurgery (Gamma Knife or CyberKnife) offers a precise, non-invasive treatment option.
If the tumor or its treatment affects hormone production, patients may need lifelong hormone therapy to maintain normal body functions.
With early diagnosis and proper treatment, the prognosis for pituitary adenomas is generally positive. Many patients experience full recovery, especially when treated with surgery and medication. However, untreated adenomas can lead to severe complications, including permanent vision loss, severe hormonal imbalances, and cardiovascular issues.
While there’s no definitive way to prevent pituitary adenomas, maintaining overall health and undergoing regular medical check-ups can aid early detection. Lifestyle adjustments such as managing stress, adopting a balanced diet, and addressing hormone-related issues can help in reducing risks.
If you experience persistent headaches, vision changes, unexplained weight fluctuations, or hormonal symptoms, consulting a specialist is essential for timely diagnosis and intervention.
WhatsApp us